维普中文期刊产品整合服务
14篇 您的检索式:作者名="PENG LB"
    题名 作者 年代 出处 被引量
1WntSa promotes differentiation of human dental papilla cells 显示文摘Peng L Ren LB Dong G 2010lnt Endod2010,43,:1
2Changes in the three-dimensional angular vestibulo-ocular reflex following intratympanic gentamicin for Meniere' s disease 显示文摘Carey JP Minor LB Peng GC 2002J Assoc Res Otolaryngol2002,3,4:1
3The draft genome of the fast growing non-timber forest species Moso Bamboo (Phyllostachys heterocycla) 显示文摘Peng ZH Lu Y Li LB 2013Nature Genetics2013,45,4:1
4The relaltionship between QT dispersion and Ventricular arrhythmia显示文摘Peng DF Zhu LB Hu ZR 1998Linchuang Xinxueguan bing Zazhi (J Clin Cardiol)1998,14,3:1
5Wnt5a promotes differentiation of human dental papilla cells显示文摘Peng L Ren LB Dong G 2010Int Endod J2010,43,5:1
6ldentifieation of a Tibetan- specific mutation in the hypoxic gene EGLN1 and its contribution to high-altitude adaptalion 显示文摘Xiang K Quzhu LB Peng Y 2013MoI Biol Evol2013,30,8:1
7Economic evaluation of first-line adjuvant chemotherapies for reseetable gastric cancer patients in China显示文摘TAN CQ PENG LB ZENG XH 2013PLoS One2013,8,83:1
8A trial-based costeffectiveness analysis of erlotinib alone versus platinum-based doublet chemotherapy as first-line therapy for eastern Asian nonsquamous non-small cell lung cancer显示文摘WANG SY PENG LB LI JH 2013PLo S One2013,8,55:1
9Cost-utility analysis of the new]y recommended adjuvant chemotherapy ~)~r resectable gastric cancer patients in the 2011 Chinese national comprehensive cancer network (NCCN) clinical practice guidelines in oncology: gastric cancer显示文摘TAN CQ PENG LB ZENG XH 2014Pharmaco Economics2014,32,3:1
10Cost-utility analysis in China: differences and difficulties compared with developed countries显示文摘PENG LB TAN CQ WAN XM 2007Pharmacoeconomics2007,25,7:1
11Inflammatory signals associated with hemodialysis显示文摘Caglar K Peng Y Pupim LB 2002Kidney Int2002,62,:1
12Increased expression of E- phA1 protein in prostate cancers correlates with high Gleason score显示文摘Peng LB Wang HY Dong Y 2013Int J Clin Exp Pathol2013,6,9:1
13Cost-effectiveness analysis of adjuvant therapy for operable breast cancer from a Chinese perspective: doxorubicin plus cyclophosphamide versus docetaxel plus cyclophosphamide显示文摘PENG LB WAN XM TAN CQ et ol 2009Pharmacoeconomics2009,27,10:1
14Cost-utility analysis in China: differences and difficulties compared with developed countries显示文摘PENG LB WAN XM TAN CQ 2007Pharmacoeconomics2007,25,7:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费